Purchase Order HHSN272201400601P
Award Date 6/10/14
Potential Completion Date 6/16/14
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $11,439.25 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Illumina, Inc. for ILLUMINA TRUSEQ REAGENT KITS. The award has no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, has previously received prime federal contracts and sub-awards from agencies like the NIH, CDC, USDA, and VA to support their genomic sequencing and analysis...
- This is a $15,395.83 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for TruSeq reagent kits. The award has no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has previously received prime contracts and subcontracts from federal agencies like NIH, CDC, USDA, and VA to provide a range of sequencing...
- This $3,277.99 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The award is for the provision of a TRUSEQ RNA SAMPLE KIT to support NIAID's research and development activities. No set-aside designation is mentioned. Illumina has received multiple prior federal...
- This firm fixed-price purchase order was awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services (HHS). The $3,421.50 contract is for the provision of TRUSEQ KITS, with a period of performance ending on July 21, 2015. The award did not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The contract, valued at $12,697.30, has no set-aside designation and is for the ultimate completion of the order by September 5, 2014. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has a history of providing...
- This is a firm fixed-price delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $13,477.18 order is for the TruSeq SBS Kit v3-HS (200 cycles), a consumable used with Illumina's sequencing platforms. The award has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and support services to various federal...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc., a for-profit manufacturer of genetic analysis products. The $13,185.44 order is for the provision of TRUSEQ kits and reagents, with no set-aside designation. Based on Illumina's background as a provider of sequencing instruments and reagents to federal agencies like the NIH, CDC, USDA, and VA, the...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for TruSeq reagent kits. The $15,266.68 award has a completion date of September 10, 2015 and does not have a set-aside designation. Through past prime contract awards, Illumina has provided a range of sequencing systems, reagents, and services to support genomic research and diagnostics across...
- This is a federal purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The $5,610 firm fixed price award has a completion date of September 12, 2014 and does not utilize any set-aside provisions. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has previously supported genomic research and diagnostic projects...
- This firm fixed-price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $8,366.17 award is for the procurement of Illumina's TruSeq DNA Sample Prep Kit Set A, which supports sample preparation for genomic sequencing. Illumina has a history of prime federal contract and subcontract...